Video

Dr. Marc Bjurlin on Predictive Models for Prostate Cancer Risk

Marc Bjurlin, DO, clinical assistant professor, department of urology, New York University (NYU) Langone Medical Center, discusses predictive models for prostate cancer risk.

One of the controversies in prostate cancer is which men require a prostate biopsy and of those men, which have a risk of having clinically significant cancer that warrants treatment, explained Bjurlin.

Bjurlin’s team built predictive models that can determine the likelihood of having cancer and of having high-risk disease. They did this using several different clinical parameters, including a multiparametric MRI of the prostate. This is used in conjunction with PSA and family history to determine if patients should get a biopsy and their likelihood of having clinically significant prostate cancer.

Newsletter

Stay up to date on the most recent and practice-changing oncology data

Latest CME

View All
Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC
Video

Tumor Board: Expert Insights on Managing Classical 𝘌𝘎𝘍𝘙 Mutations, 𝘌𝘎𝘍𝘙 Exon 20 Insertions, and Atypical 𝘌𝘎𝘍𝘙 Mutations in Metastatic NSCLC

Jun 6th 2025 - Jul 12th 2025

online-activity
Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation
Video

Medical Crossfire®: Expert Perspectives on Targeting c-Met Overexpression and 𝘔𝘌𝘛 Genomic Alterations in NSCLC – Unveiling the Complexities of 𝘔𝘌𝘛 Dysregulation

Jun 6th 2025 - Jul 12th 2025

online-activity
Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing
Video

Evolving Treatment Strategies in Pancreatic Cancer: Current Standards, Emerging Targets, and the Role of Molecular Testing

Jun 5th 2025 - Jul 12th 2025

online-activity